Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer

Published:2015-09-15 Issue:5 Volume:76 Page:933-937
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Lee Hyo-Sun,Lee Yun-Gyoo,Koo Dong-Hoe,Oh Sukjoong,Nam Heerim,Song Jae-Uk,Lim Seong Yong,Lim Si-young,Lee Seung-Sei

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2864-y.pdf

Reference22 articles.

1. Buccheri G, Ferrigno D (2004) Prognostic factors of small cell lung cancer. Hematol Oncol Clin North Am 18(2):445–460. doi: 10.1016/j.hoc.2003.12.011

2. Johnson BE, Janne PA (2004) Basic treatment considerations using chemotherapy for patients with small cell lung cancer. Hematol Oncol Clin North Am 18(2):309–322. doi: 10.1016/j.hoc.2003.12.008

3. Govindan R, Page N, Morgensztern D, Read W, Tierney R, Vlahiotis A, Spitznagel EL, Piccirillo J (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24(28):4539–4544. doi: 10.1200/jco.2005.04.4859

4. Chua YJ, Steer C, Yip D (2004) Recent advances in management of small-cell lung cancer. Cancer Treat Rev 30(6):521–543. doi: 10.1016/j.ctrv.2004.06.003

5. Kurup A, Hanna NH (2004) Treatment of small cell lung cancer. Crit Revi Oncol Hematol 52(2):117–126. doi: 10.1016/j.critrevonc.2004.08.005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ifosfamide - History, efficacy, toxicity and encephalopathy;Pharmacology & Therapeutics;2023-03

2. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review;Cancers;2022-05-17

3. Irinotecan and Ifosfamide Combination is an Effective and Safe Option in Patients with Refractory Small Cell Lung Cancer: A Retrospective Cross-Sectional Study;Eurasian Journal of Medicine and Oncology;2020

4. Bacterial Pneumonia in Patients with Cancer;Clinics in Chest Medicine;2017-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3